Dai-ichi Life Insurance Company’s Xerox XRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-230,000
Closed -$4.64M 525
2022
Q1
$4.64M Sell
230,000
-70,000
-23% -$1.47M 0.07% 213
2021
Q4
$6.79M Buy
300,000
+110,000
+58% +$2.23M 0.09% 185
2021
Q3
$3.83M Buy
190,000
+20,000
+12% +$454K 0.05% 251
2021
Q2
$3.99M Buy
170,000
+20,000
+13% +$484K 0.05% 248
2021
Q1
$3.64M Buy
150,000
+33,000
+28% +$789K 0.05% 249
2020
Q4
$2.71M Buy
+117,000
New +$2.47M 0.04% 286
2020
Q1
Sell
-7,053
Closed -$260K 539
2019
Q4
$260K Hold
7,053
0.01% 506
2019
Q3
$211K Hold
7,053
0.01% 510
2019
Q2
$250K Hold
7,053
0.01% 509
2019
Q1
$226K Buy
+7,053
New +$199K 0.01% 505
2018
Q2
Sell
-7,053
Closed -$203K 534
2018
Q1
$203K Hold
7,053
﹤0.01% 509
2017
Q4
$206K Hold
7,053
﹤0.01% 497
2017
Q3
$235K Hold
7,053
0.01% 483
2017
Q2
$203K Sell
7,053
-1,904
-21% -$53.8K ﹤0.01% 490
2017
Q1
$263K Sell
8,957
-4,640
-34% -$134K 0.01% 489
2016
Q4
$313K Buy
+13,597
New +$339K 0.01% 477

Other funds holding XRX

Dai-ichi Life Insurance Company's XRX Position: Q2 2022 in Review

Dai-ichi Life Insurance Company sold out of Xerox (XRX) in Q2 2022, closing a stake of 230,000 shares — an estimated $4.64M sold.

Dai-ichi Life Insurance Company first reported a position in XRX in Q4 2016 and held it in 16 quarters. The position peaked at $6.79M in Q4 2021. 311 funds tracked by Wall St. Rank hold XRX as of Q2 2022.

  • Dai-ichi Life Insurance Company reported no remaining Xerox position as of Q2 2022 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 230,000 Xerox shares in Q2 2022, an estimated $4.64M.
  • Dai-ichi Life Insurance Company first reported a position in Xerox in Q4 2016 and held it in 16 quarters.
  • Dai-ichi Life Insurance Company's Xerox position peaked at $6.79M in Q4 2021.
  • 311 funds tracked by Wall St. Rank held Xerox as of Q2 2022.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2022, filed 12 Aug 2022.